Cancer

November 9, 2017

Vanderbilt joins national neurofibromatosis network

The Vanderbilt-Ingram Cancer Center Neurofibromatosis (NF) Clinic has joined the Children’s Tumor Foundation NF Clinic Network.

By Tom Wilemon
November 3, 2017

Lung cancer survivors and caregivers invited to VUMC event Nov. 16

Lung cancer survivors and their caregivers are invited to attend a free educational evening at Vanderbilt University Medical Center (VUMC) Thursday, Nov. 16, 5:30 – 8:30 p.m., at the University Club, 2402 Garland Ave.

By VUMC News and Communications
November 2, 2017

Liquid biopsies help reveal lung cancer mutations

Cancer investigators led by researchers at Vanderbilt-Ingram Cancer Center (VICC) have co-developed a liquid biopsy blood-based assay used to identify specific gene mutations associated with the development or relapse of small-cell lung cancer (SCLC).

By VUMC News and Communications
(iStock)
October 26, 2017

Study to test combination therapy for breast cancer

Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

By VUMC News and Communications
October 25, 2017

Vanderbilt-Ingram Cancer Center patients treated with new FDA-approved CAR-T therapy

Vanderbilt-Ingram Cancer Center has been selected as one of the few authorized treatment centers in the United States approved to administer the first FDA- approved chimeric antigen receptor T cell (CAR-T) therapy for treatment of adult patients with a specific type of lymphoma. VICC is the only cancer center in a seven-state region of the Southeast authorized to deliver the new immunotherapy.

By VUMC News and Communications
October 20, 2017

My Southern Health: How to assess your breast cancer risk

Do you know what it means to be at “high” or “elevated” risk for developing breast cancer? Do you know if you are at high risk?

By VUMC News and Communications
October 18, 2017

Calcium intake and colorectal cancer

Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered.
By Leigh MacMillan
October 17, 2017

Researchers find novel mechanism of resistance to anti-cancer drugs

Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance.
By Leigh MacMillan
October 5, 2017

Predators’ fund powers fight against childhood cancer

Nashville Predators goaltender Pekka Rinne, Predators executive leaders, executives from Tri Star Energy (Twice Daily) and team mascot Gnash recently presented the proceeds of the team’s 365 Pediatric Cancer Fund to Monroe Carell Jr. Children’s Hospital at Vanderbilt.
By Christina Echegaray
October 4, 2017

Boosting sarcoma cell death

A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas.
By Leigh MacMillan
September 18, 2017

New cutting-edge treatment for type of pediatric leukemia offered at Monroe Carell Jr. Children’s Hospital at Vanderbilt 

By Christina Echegaray
September 13, 2017

Chic Awearness event supports VUMC ovarian cancer research

The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:30 p.m., at Prima Restaurant, 700 12th Ave. South.
By VUMC News and Communications
August 31, 2017

Pancreatic cancer development

Elevated levels of the factor G-CSF appear to promote the development of aggressive pancreatic cancer, suggesting a new therapeutic approach for this devastating disease.
By Leigh MacMillan
1 … 36 37 38 39 40 … 69